PRISMAP+ PRISMAP+ - Furthering the European Medical Radionuclide Programme
- Coordinator
- Organisation Europeenne Pour La Recherche Nucleaire, Switzerland
- Runs
- 1 May 2026 to 30 April 2029
- Status
- Running
- EU funding
- €5.0m
- Total cost
- €5.0m
- Partners
- 24 organisations in 14 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101287718
What the project is doing
In the project's own words, from its summary on CORDIS.
PRISMAP + - furthering the European Medical Radionuclide Programme, federates a consortium of 23 beneficiary or associate institutes. Nuclear medicine and research with novel radiopharmaceuticals is fast evolving with the 1st blockbuster treatment radiopharmaceutical Pluvicto® on the market last year. Based on recommendations from the Council of Europe to consolidate the European Radioisotope Valley Initiative programme and associated R&D for medical radionuclides, and therefore to extend the successful PRISMAP programme, PRISMAP + is submitted to this call to coordinate the access for biomedical researchers in Europe to a consortium of leading facilities.
It extends the supply chain in geographical and scope from the maturing PRISMAP consortium, including intense neutron sources, proton and alpha accelerators, mass separation, including 2 new operating accelerators, and hosting researchers in our biomedical hubs. Planned for 2026-2029, the access platform radionuclides.eu will display relevant evolving information, manage the access in the project selection and publish relevant information as projects outcomes and dissemination become necessary.
Accesses to services will furthermore be provided in our biomedical hubs, extended to larger geographical reach in Norway and Greece.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Organisation Europeenne Pour La Recherche Nucleaire | Geneve 23 | Switzerland | Coordinator |
| Eanm Forschungs GmbH | Wien | Austria | Participant |
| Medizinische Universitat Innsbruck | Innsbruck | Austria | Participant |
| Jrc -Joint Research Centre- European Commission | Bruxelles / Brussel | Belgium | Associatedpartner |
| Katholieke Universiteit Leuven | Leuven | Belgium | Participant |
| Studiecentrum Voor Kernenergie / Centre D'etude De L'energie Nucleaire | Bruxelles / Brussel | Belgium | Participant |
| Universiteit Gent | Gent | Belgium | Participant |
| Centre Hospitalier Universitaire Vaudois | Lausanne | Switzerland | Participant |
| Paul Scherrer Institut | Villigen Psi | Switzerland | Participant |
| Universite De Geneve | Geneve | Switzerland | Participant |
| Helmholtz-Zentrum Dresden-Rossendorf eV | Dresden | Germany | Participant |
| Klinikum Der Technischen Universität München (tum Klinikum) | Muenchen | Germany | Participant |
| Danmarks Tekniske Universitet | Kongens Lyngby | Denmark | Participant |
| Bioemission Technology Solutions SA | Gerakas (Athina) | Greece | Participant |
| Groupement Interet Public Arronax | Saint Herblain | France | Participant |
| Institut Max Von Laue - Paul Langevin | Grenoble | France | Participant |
| Istituto Nazionale Di Fisica Nucleare | Frascati | Italy | Participant |
| Latvijas Universitate | Riga | Latvia | Associatedpartner |
| Universitetet I Oslo | Oslo | Norway | Associatedpartner |
| Narodowe Centrum Badan Jadrowych | Otwock | Poland | Participant |
| Ist-Id Associacao Do Instituto Superior Tecnico Para a Investigacao E O Desenvolvimento | Lisboa | Portugal | Participant |
| Institutul National De Cercetare-Dezvoltare Pentru Fizica Si Inginerie Nucleara-Horia Hulubei | Magurele | Romania | Participant |
| Npl Management Limited | Middlesex | United Kingdom | Participant |
| The University of Manchester | Manchester | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI